The number of cases of mpox, formerly known as monkeypox, has spiked in the Big Apple since October, the New York City ...
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by ...
The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
Lower dose of monkeypox vaccine is found to be safe with equal six-week antibody response, promising for vaccination strategies.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
KINSHASA, Congo (AP) — Congo is struggling to contain its biggest mpox outbreak, and scientists say a new form of the disease ...
This was used as a dose-saving strategy as supplies were initially limited. The vaccine has been shown to be efficacious in studies using real-world data from the 2022 and onward outbreak among ...
World Immunization Week: 507 vaccines in late-stage development, 88 using mRNA tech to prevent TB, malaria, flu, COVID-19, ...
This is a study of a vaccine approved by the U.S. Food and Drug Administration (FDA) for adults to prevent monkeypox, now called mpox ... approved the use of two (0.5 mL) doses of JYNNEOS given ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) vaccine candidate ... as 2 doses 6 months apart ...
Context: Latest one-dose ... the vaccine. We should wait for at least 10,000 or more children in the US to be vaccinated and observe the response,” Leung said. The US Food and Drug ...